Galapagos NV (FRA:GXE)
28.16
+0.04 (0.14%)
At close: Jan 29, 2026
Galapagos NV Employees
Galapagos NV had 558 employees as of June 30, 2025. The number of employees decreased by 146 or -20.74% since the number was reported on December 31, 2024.
Employees
558
Change
-146
Growth
-20.74%
Revenue / Employee
€407,558
Profits / Employee
€619,254
Market Cap
1.87B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 558 | -146 | -20.74% |
| Dec 31, 2024 | 704 | -419 | -37.31% |
| Dec 31, 2023 | 1,123 | -215 | -16.07% |
| Dec 31, 2022 | 1,338 | 29 | 2.22% |
| Dec 31, 2021 | 1,309 | -180 | -12.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Paul Hartmann AG | 10,082 |
| Mainova AG | 3,416 |
| Gelsenwasser AG | 1,898 |
| Maschinenfabrik Berthold Hermle AG | 1,607 |
| EUROKAI GmbH & Co. KGaA | 950 |
| tonies SE | 567 |
| Lechwerke AG | 459 |
| Northern Data AG | 199 |
Galapagos NV News
- 26 days ago - Galapagos (GLPG) to Cease Cell Therapy Operations - GuruFocus
- 26 days ago - Galapagos NV: Galapagos Announces Board Decision to Initiate Wind-Down of Cell Therapy Activities - Finanz Nachrichten
- 26 days ago - Galapagos Announces Board Decision to Initiate Wind-Down of Cell Therapy Activities - GlobeNewsWire
- 5 weeks ago - Galapagos: Pivoting From Clinical Risk To Strategic Capital Allocation - Seeking Alpha
- 6 weeks ago - Galapagos (GLPG) Achieves Key Milestone in Dermatomyositis Study - GuruFocus
- 6 weeks ago - Galapagos NV: Galapagos Announces Topline Results from Two Phase 3-Enabling Studies with Selective TYK2 Inhibitor GLPG3667 in Dermatomyositis and Systemic Lupus Erythematosus - Finanz Nachrichten
- 7 weeks ago - GLPG Crosses Above Average Analyst Target - Nasdaq
- 7 weeks ago - Galapagos (GLPG) Showcases Promising Phase 2 Results for CAR T-Cell Therapy - GuruFocus